The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The current study describes the impact of particle size and/or molecular targeting (epidermal growth factor, EGF) on the in vivo transport of block copolymer micelles (BCMs) in athymic mice bearing human breast cancer xenografts that express differential levels of EGF receptors (EGFR). BCMs with diameters of 25 nm (BCM-25) and 60 nm (BCM-60) were labeled with indium-111 ((111)In) or a fluorescent probe to provide a quantitative and qualitative means of evaluating their whole body, intratumoral, and subcellular distributions. BCM-25 was found to clear rapidly from the plasma compared to BCM-60, leading to an almost 2-fold decrease in their total tumor accumulation. However, the tumoral clearance of BCM-25 was delayed through EGF functionalization, enabling the targeted BCM-25 (T-BCM-25) to achieve a comparable level of total tumor deposition as the nontargeted BCM-60 (NT-BCM-60). Confocal fluorescence microscopy combined with MATLAB analyses revealed that NT-BCM-25 diffuses further away from the blood vessels (D(mean) = 42 +/- 9 microm) following extravasation, compared to NT-BCM-60 which mainly remains in the perivascular regions (D(mean) = 23 +/- 4 microm). The introduction of molecular targeting imposes the "binding site barrier" effect, which retards the tumor penetration of T-BCM-25 (D(mean) = 29 +/- 7 microm, p < 0.05). The intrinsic nuclear translocation property of EGF/EGFR leads to a significant increase in the nuclear uptake of T-BCM-25 in vitro and in vivo via active transport. Overall, these results highlight the need to consider multiple design parameters in the development of nanosystems for delivery of anticancer agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some previous studies, it was shown that sizes from 50 nm–100 nm are effective in preclinical models, suggesting ideal particle size distribution is necessary for efficacy of polymeric micelles [253, 254].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [254]
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358
Self-citationMicellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota, T., Milenic, D. E., Whitlow, M. D., & Schlom, J. (1992) · PubMed · Cited by 819
Research works printed but not linked: 6
- Yokota T., 1992, Cancer Res., 52, 3402
- Amiji, M. M.Nanotechnology for cancer therapy;CRC/Taylor & Francis:Boca Raton, 2007; p817,[8] of plates.
- Yuan F., 1995, Cancer Res., 55, 3752
- Juweid M., 1992, Cancer Res., 52, 5144
- Thurber G. M., 2008, Trends Pharmacol. Sci., 29, 57
- Costantini D. L., 2008, Cancer Biother. Radiopharm., 23, 3
Cited by
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., & Tsourkas, A. (2012) · Science · doi:10.1126/science.1226338 · Cited by 1,322
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy
Lee, N., Yoo, D., Ling, D., Cho, M. H., Hyeon, T., & Cheon, J. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00112 · Cited by 1,005
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Ren, J. M., McKenzie, T. G., Fu, Q., Wong, E. H. H., Xu, J., An, Z., Shanmugam, S., Davis, T. P., Boyer, C., & Qiao, G. G. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00008 · Cited by 839
Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
“In some previous studies, it was shown that sizes from 50 nm–100 nmare effective in preclinical models, suggesting ideal particle size distribution is necessary for efficacy of polymeric micelles [253,254].”
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Srinivasarao, M., Galliford, C. V., & Low, P. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4519 · Cited by 671
Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors
Dai, Q., Wilhelm, S., Ding, D., Syed, A. M., Sindhwani, S., Zhang, Y., Chen, Y. Y., MacMillan, P., & Chan, W. C. W. (2018) · ACS Nano · doi:10.1021/acsnano.8b03900 · Cited by 658
The role of micelle size in tumor accumulation, penetration, and treatment
Wang, J., Mao, W., Lock, L. L., Tang, J., Sui, M., Sun, W., Cui, H., Xu, D., & Shen, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b02017 · Cited by 635
Deng, C., Jiang, Y., Cheng, R., Meng, F., & Zhong, Z. (2012) · Nano Today · doi:10.1016/j.nantod.2012.08.005 · Cited by 562
Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications
Kannan, R. M., Nance, E., Kannan, S., & Tomalia, D. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12280 · Cited by 542
Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
Zhong, Y., Meng, F., Deng, C., & Zhong, Z. (2014) · Biomacromolecules · doi:10.1021/bm5003009 · Cited by 541
Meng, H., Xue, M., Xia, T., Ji, Z., Tarn, D. Y., Zink, J. I., & Nel, A. E. (2011) · ACS Nano · doi:10.1021/nn200809t · Cited by 509
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
Nanocarriers for drug delivery applications
Chamundeeswari, M., Jeslin, J., & Verma, M. L. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00841-1 · Cited by 444
Nanoprecipitation and the “Ouzo effect”: Application to drug delivery devices
Lepeltier, E., Bourgaux, C., & Couvreur, P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.009 · Cited by 440
Obstacles and opportunities in a forward vision for cancer nanomedicine
de Lázaro, I., & Mooney, D. J. (2021) · Nature Materials · doi:10.1038/s41563-021-01047-7 · Cited by 439
Engineered nanomedicines with enhanced tumor penetration
Ding, J., Chen, J., Gao, L., Jiang, Z., Zhang, Y., Li, M., Xiao, Q., Lee, S. S., & Chen, X. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100800 · Cited by 420
Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery
Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., Christie, R. J., Yamada, N., Ogura, T., Kano, M. R., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.342 · Cited by 412
Entry of nanoparticles into cells: the importance of nanoparticle properties
Zhao, J., & Stenzel, M. H. (2018) · Polymer Chemistry · doi:10.1039/c7py01603d · Cited by 391
Bridging Bio–Nano Science and Cancer Nanomedicine
Björnmalm, M., Thurecht, K. J., Michael, M., Scott, A. M., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.7b04855 · Cited by 382
Black, K. C. L., Wang, Y., Luehmann, H. P., Cai, X., Xing, W., Pang, B., Zhao, Y., Cutler, C. S., Wang, L. V., Liu, Y., et al. (2014) · ACS Nano · doi:10.1021/nn406258m · Cited by 365
Mohan, P., & Rapoport, N. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100269f · Cited by 331
Tumour-on-a-chip provides an optical window into nanoparticle tissue transport
Albanese, A., Lam, A. K., Sykes, E. A., Rocheleau, J. V., & Chan, W. C. W. (2013) · Nature Communications · doi:10.1038/ncomms3718 · Cited by 330
Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
Psimadas, D., Georgoulias, P., Valotassiou, V., & Loudos, G. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23146 · Cited by 322
The Shape of Things to Come: Importance of Design in Nanotechnology for Drug Delivery
Liu, Y., Tan, J., Thomas, A., Ou-Yang, D., & Muzykantov, V. R. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.156 · Cited by 299
Nanogel: A Versatile Nano-Delivery System for Biomedical Applications
Yin, Y., Hu, B., Yuan, X., Cai, L., Gao, H., & Yang, Q. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030290 · Cited by 289
Design considerations for nanotherapeutics in oncology
Stylianopoulos, T., & Jain, R. K. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.015 · Cited by 280
Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
Zhang, M., Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Liu, Y., Liu, X., Su, K., & Shi, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.033 · Cited by 274
Strategies to improve tumor penetration of nanomedicines through nanoparticle design
Zhang, Y., Lin, R., Li, H., He, W., Du, J., & Wang, J. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1519 · Cited by 268
Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 264
Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
Durymanov, M., & Reineke, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00971 · Cited by 254
Emerging applications for living crystallization-driven self-assembly
MacFarlane, L., Zhao, C., Cai, J., Qiu, H., & Manners, I. (2021) · Chemical Science · doi:10.1039/d0sc06878k · Cited by 252
Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids
Tchoryk, A., Taresco, V., Argent, R. H., Ashford, M., Gellert, P. R., Stolnik, S., Grabowska, A., & Garnett, M. C. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00136 · Cited by 243
Photoswitchable nanoparticles for in vivo cancer chemotherapy
Tong, R., Chiang, H. H., & Kohane, D. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315336110 · Cited by 227
Miao, L., Newby, J. M., Lin, C. M., Zhang, L., Xu, F., Kim, W. Y., Forest, M. G., Lai, S. K., Milowsky, M. I., Wobker, S. E., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02776 · Cited by 221
Zhou, Q., Dong, C., Fan, W., Jiang, H., Xiang, J., Qiu, N., Piao, Y., Xie, T., Luo, Y., Li, Z., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119902 · Cited by 218
Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., & Li, S.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.029 · Cited by 213
Zhao, P., Zheng, M., Yue, C., Luo, Z., Gong, P., Gao, G., Sheng, Z., Zheng, C., & Cai, L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.019 · Cited by 204
Enhancing tumor penetration of nanomedicines
Sun, Q., Ojha, T., Kiessling, F., Lammers, T., & Shi, Y. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00068 · Cited by 198
The new era of nanotechnology, an alternative to change cancer treatment
Jurj, A., Braicu, C., Pop, L.-A., Tomuleasa, C., Gherman, C., & Berindan-Neagoe, I. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s142337 · Cited by 198
Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
Durymanov, M. O., Rosenkranz, A. A., & Sobolev, A. S. (2015) · Theranostics · doi:10.7150/thno.11742 · Cited by 189
Intratumoral Drug Delivery with Nanoparticulate Carriers
Holback, H., & Yeo, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0360-y · Cited by 187
Cong, Y., Ji, L., Gao, Y., Liu, F., Cheng, D., Hu, Z., Qiao, Z., & Wang, H. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201900135 · Cited by 184
Wang, Y., Su, H.-H., Yang, Y., Hu, Y., Zhang, L., Blancafort, P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.250 · Cited by 183
In vivo applications of magnetic nanoparticle hyperthermia
Hilger, I. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.832815 · Cited by 172
Effect of size on biological properties of nanoparticles employed in gene delivery
Prabha, S., Arya, G., Chandra, R., Ahmed, B., & Nimesh, S. (2016) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.3109/21691401.2014.913054 · Cited by 171
Eetezadi, S., Ekdawi, S. N., & Allen, C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.001 · Cited by 166
Self-citationEffects of Size and Surface Charge of Polymeric Nanoparticles on in Vitro and in Vivo Applications
Sadat, S. M. A., Jahan, S. T., & Haddadi, A. (2016) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2016.72011 · Cited by 165
Waite, C. L., & Roth, C. M. (2012) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v40.i1.20 · Cited by 156
Bolat, Z. B., İşlek, Z., Demir, B. N., Yılmaz, E. N., Şahin, F., & Üçışık, M. H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00050 · Cited by 163
The in vivo fate of polymeric micelles
Cai, Y., Qi, J., Lu, Y., He, H., & Wu, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114463 · Cited by 154
Wang, J., Zhu, M., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113974 · Cited by 153
Niu, Y., Zhu, J., Li, Y., Shi, H., Gong, Y., Li, R., Huo, Q., Ma, T., & Liu, Y. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.012 · Cited by 154
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
Jahan, S. T., Sadat, S. M. A., Walliser, M., & Haddadi, A. (2017) · Journal of Drug Delivery · doi:10.1155/2017/9090325 · Cited by 152
Recent Advances in the Generation of Antibody–Nanomaterial Conjugates
Sivaram, A. J., Wardiana, A., Howard, C. B., Mahler, S. M., & Thurecht, K. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700607 · Cited by 134
Gu, G., Gao, X., Hu, Q., Kang, T., Liu, Z., Jiang, M., Miao, D., Song, Q., Yao, L., Tu, Y., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.036 · Cited by 144
Nanomedicine-mediated cancer stem cell therapy
Shen, S., Xia, J., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.037 · Cited by 134
Nuclear drug delivery for cancer chemotherapy
Sui, M., Liu, W., & Shen, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.041 · Cited by 134
Nanomedicine as an emerging approach against intracellular pathogens
Li, B., & Armstead (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s27285 · Cited by 131
Hu, J., Miura, S., Na, K., & Bae, Y. H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.007 · Cited by 128
Challenges and opportunities for siRNA-based cancer treatment
Wang, T., Shigdar, S. L., Shamaileh, H. A., Gantier, M. P., Yin, W., Xiang, D., Wang, L., Zhou, S.-F., Hou, Y., Wang, P., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.045 · Cited by 129
Yu, Q., Qiu, Y., Li, J., Tang, X., Wang, X., Cun, X., Xu, S., Liu, Y., Li, M., Zhang, Z., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.040 · Cited by 120
Zhu, Z., Xie, C., Liu, Q., Xu, Z. C., Zheng, X., Wu, W., Li, R., Ding, Y., Jiang, X., & Liu, B. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.072 · Cited by 122
Cun, X., Ruan, S., Chen, J., Zhang, L., Li, J., He, Q., & Gao, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.002 · Cited by 117
Nanoparticles for antiparasitic drug delivery
Sun, Y., Chen, D., Pan, Y., Qu, W., Hao, H., Wang, X., Liu, Z., & Xie, S. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1692968 · Cited by 136
Maya, S., Kumar, L. G., Sarmento, B. F. C. C., Rejinold, N. S., Menon, D., Nair, S. V., & Jayakumar, R. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.12.032 · Cited by 113
Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue
Munir, M. U. (2022) · Cancers · doi:10.3390/cancers14122904 · Cited by 121
Sun, Y., Ma, W., Yang, Y., He, M., Li, A., Bai, L., Yu, B., & Yu, Z. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.04.005 · Cited by 116
Caster, J. M., Yu, S. K., Patel, A. N., Newman, N. J., Lee, Z. J., Warner, S. B., Wagner, K. T., Roche, K. C., Tian, X., Min, Y., et al. (2017) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.03.002 · Cited by 111
Shuhendler, A. J., Prasad, P., Leung, M., Rauth, A. M., DaCosta, R. S., & Wu, X. Y. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200006 · Cited by 111
Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy
Si, J., Shao, S., Shen, Y., & Wang, K. (2016) · Small · doi:10.1002/smll.201601282 · Cited by 109
Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery
Guven, A., Rusakova, I. A., Lewis, M. T., & Wilson, L. J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.060 · Cited by 111
Rad, A. T., Chen, C., Aresh, W., Xia, Y., Lai, P., & Nieh, M. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b21609 · Cited by 106
Chen, Y., Zhang, X.-H., Cheng, D.-B., Zhang, Y., Liu, Y., Ji, L., Guo, R., Chen, H., Ren, X.-K., Chen, Z., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c00118 · Cited by 101
Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles
Zhang, B., Shen, S., Liao, Z., Shi, W., Wang, Y., Zhao, J., Hu, Y., Yang, J., Chen, J., Mei, H., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.046 · Cited by 103
Xu, Y., Zi, Y., Lei, J., Mo, X., Shao, Z., Wu, Y., Tian, Y., Li, D., & Mu, C. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.115858 · Cited by 101
Kang, Y. M., Kim, G. H., Kim, J. I., Kim, D. Y., Lee, B. N., Yoon, S. M., Kim, J. H., & Kim, M. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.007 · Cited by 99
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs
Sabit, H., Abdel-Hakeem, M. A., Shoala, T., Abdel-Ghany, S. E., Abdel-Latif, M. M., Almulhim, J., & mansy, M. I. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081566 · Cited by 112
Fan, J., Zeng, F., Wu, S., & Wang, X. (2012) · Biomacromolecules · doi:10.1021/bm301424r · Cited by 99
Near-Infrared Laser-Driven in Situ Self-Assembly as a General Strategy for Deep Tumor Therapy
Liu, F., Cong, Y., Qi, G., Ji, L., Qiao, Z., & Wang, H. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03174 · Cited by 94
Ekdawi, S. N., Stewart, J., Dunne, M., Stapleton, S., Mitsakakis, N., Dou, Y. N., Jaffray, D. A., & Allen, C. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.006 · Cited by 102
Self-citationZhang, Y., Wang, B., Zhao, R., Zhang, Q., & Kong, X. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111099 · Cited by 96
Datta, N. R., Krishnan, S., Speiser, D. E., Neufeld, E., Kuster, N., Bodis, S., & Hofmann, H. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.09.016 · Cited by 92
Ghosh, A., Xu, W., Gupta, N., & Gracias, D. H. (2020) · Nano Today · doi:10.1016/j.nantod.2019.100836 · Cited by 101
In vitromicrofluidic models of tumor microenvironment to screen transport of drugs and nanoparticles
Özçelikkale, A., Moon, H., Linnes, M. P., & Han, B. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1460 · Cited by 95
Xu, Y., Wu, H. C., Huang, J., Qian, W., Martinson, D. E., Ji, B., Li, Y., Wang, Y. A., Yang, L. P. H., & Mao, H. Z. (2020) · Theranostics · doi:10.7150/thno.39560 · Cited by 90
Small molecules as cancer targeting ligands: Shifting the paradigm
Kaur, N., Popli, P., Tiwary, N., & Swami, R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.032 · Cited by 91
Liu, T., Zhang, D., Song, W., Tang, Z., Zhu, J., Ma, Z., Wang, X., Chen, X., & Tong, T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.02.001 · Cited by 82
Huang, K., Boerhan, R., Liu, C., & Jiang, G. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00726 · Cited by 74
From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers
MacEwan, S. R., & Chilkoti, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201610819 · Cited by 78
Metadata
- Authors
- Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Allen, Christine
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-05-26
- Volume
- 7
- Issue
- 4
- Pages
- 1195-1208
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1985006200
- Cited by
- 349
- References
- 46
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 18 · 2023: 15 · 2022: 10 · 2021: 24 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 35 · 2016: 26 · 2015: 24 · 2014: 28 · 2013: 26 · 2012: 24
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- polymeric nanoparticles, block copolymer micelles, particle size, molecular targeting, epidermal growth factor, EGFR, intratumoral distribution, subcellular localization, tumor penetration, nuclear translocation, tumor xenografts, breast cancer, indium-111 labeling, nanoparticle clearance
- MeSH terms
- Animals, Breast Neoplasms, Drug Carriers, Epidermal Growth Factor, Female, Humans, Mice, Nude, Particle Size, Polymers, Microscopy, Confocal, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Nanoparticles, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.